We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rapid Hemostasis System for Gunshot Wounds

By HospiMedica International staff writers
Posted on 20 Feb 2014
A novel device seals gunshot wounds in the pelvis or shoulder area in just fifteen seconds, providing the necessary hemostasis while the patient is being transported. More...


The XStat device is a syringe-like applicator that injects tablet-sized sponges into wounds that are not amenable to tourniquet application. The sponges, which are standard medical sponges coated with a hemostatic agent and then compressed, expand once they come in contact with liquid, rapidly filling a substantially larger volume than their compressed state. Besides helping to block blood flow, the sponges also provide a surface on which blood can begin to clot. And because the sponges have to be eventually removed, each has a tiny radiopaque marker so that any remaining in the body can be spotted on X-ray.

Two applicator sizes are under development: a 30 mm diameter applicator for larger wounds and a 12 mm diameter applicator for narrow wound tracks. The XStat-30 applicator includes a telescoping handle that can be stored in a shortened state to maximize compactness, as well as a sealed valve tip designed to prevent fluid ingress and minimize the risk of premature sponge expansion. The XStat-12 applicator consists of a narrower cylindrical applicator body with a frangible tip and a detachable plunger. The applicator body includes a finger flange with snap-fit features to secure multiple devices for low-profile packaging and storage.

In a preclinical model with aggressive noncompressible hemorrhaging, the Xstat devices provided statistically significant improvement in hemostasis and survival 60 minutes after injury even with a large reduction in blood loss, resuscitation fluid requirement, and medic treatment time, compared to conventional hemorrhage control dressings. The XStat devices are products of RevMedx (Wilsonville, OR, USA), and are currently an investigational product in the United States.

“It's primarily intended for deep wounds with heavy bleeding inside, with no way of putting direct pressure on the wound, and no way to wrap a tourniquet around it,” said Anthony Pusateri, PhD, portfolio manager of the US Department of Defense (Washington DC, USA) Hemorrhage and Resuscitation Research and Development Program. “Basically, it's designed for use in the axillary and inguinal regions, or the junction of the legs and arms with the torso - too high for a tourniquet and too deep for a dressing.”

Related Links:

RevMedx



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.